JAPANESE FOUNDATION FOR CANCER RESEARCH
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1908-04-02
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.jfcr.or.jp
Clinical Trials
14
Active:1
Completed:8
Trial Phases
4 Phases
Phase 1:2
Phase 2:3
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Not Applicable
8 (57.1%)Phase 2
3 (21.4%)Phase 1
2 (14.3%)Phase 3
1 (7.1%)Randomized Phase III Trial for Evaluating the Efficacy of Adjuvant Abemaciclib in Patients With Locoregional Recurrence of Hormone Receptor-positive, HER2-negative Breast Cancer. JCOG2313, AURA Trial.
Not Applicable
Recruiting
- Conditions
- Breast CancerLocoregional RecurrenceAbemaciclibEndocrine Therapy
- Interventions
- Drug: Endocrine therapy + Abemaciclib
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- Japanese Foundation for Cancer Research
- Target Recruit Count
- 290
- Registration Number
- NCT07190443
- Locations
- 🇯🇵
Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan
A Phase III Study of Bevacizumab and Paclitaxel in Combination with Atezolizumab As a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer
Phase 3
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Japanese Foundation for Cancer Research
- Target Recruit Count
- 280
- Registration Number
- NCT04732598
- Locations
- 🇯🇵
Cancer Institute Hospital of JFCR, Tokyo, Japan
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
Phase 1
Completed
- Conditions
- Esophageal Cancer
- First Posted Date
- 2007-11-20
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Japanese Foundation for Cancer Research
- Target Recruit Count
- 6
- Registration Number
- NCT00561275
- Locations
- 🇯🇵
Takuya Takayama M.D.Ph.D, Tokyo, Japan
News
No news found